Breaking News

AstraZeneca Takes Next Steps Towards Broad Access to Oxford’s COVID-19 Vaccine

Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond

By: Contract Pharma

Contract Pharma Staff

AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII).   The company reached a $750 million agreement with CEPI and Gavi to support the manufacturing, procurement and distribution of 300 million doses of the vaccine, with delivery starting by the end of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters